Ginkgo Bioworks Bets Big on Autonomous Labs to Solve Biology's Reproducibility Crisis

The synthetic biology company is building a modular, AI-driven lab automation platform to accelerate scientific discovery.

Apr. 3, 2026 at 8:07pm

Got story updates? Submit your updates here. ›

A highly structured abstract painting in muted earth tones, featuring sweeping geometric arcs, concentric circles, and precise botanical spirals, conceptually representing the complex interplay of hardware, software, and data that powers Ginkgo Bioworks' autonomous lab platform.Ginkgo Bioworks' ambitious autonomous lab platform aims to revolutionize the pace and reliability of biological research by integrating hardware, software, and data in a closed-loop system.Boston Today

Ginkgo Bioworks, a leading synthetic biology company, is making a major bet on autonomous labs as the solution to the reproducibility crisis plaguing modern biology. By combining reconfigurable automation hardware, orchestration software, remote support, and structured data capture, Ginkgo aims to create a platform that can run complex experiments at scale, learn from the results, and rapidly iterate, all with minimal human involvement. A recent demonstration showed an autonomous loop running 36,000 reactions and generating 150,000 data points, a feat traditional labs would struggle to match. However, the company faces skepticism around the technical and financial challenges of building such an ambitious system.

Why it matters

The reproducibility crisis in biology costs an estimated $28 billion annually in the U.S. alone, as flawed experiments and unreliable data undermine scientific progress. Ginkgo believes that treating this as a hardware and software problem, rather than just a cultural one, is the key to unlocking faster, more reliable biological research and engineering. If successful, their autonomous lab platform could transform the pace and quality of innovation across fields like medicine, agriculture, and materials science.

The details

Ginkgo's autonomous lab architecture consists of several key components: Reconfigurable Automation Carts (RACs) that house instruments and robotic handling, the Catalyst software platform for orchestrating workflows, the Apex remote support system, and the Datapoints program for structured data capture. Together, these layers aim to create a closed-loop system where AI can design experiments, the lab executes them, and the results feed back into the next round of testing. A recent demonstration with OpenAI showed this loop running 36,000 reactions across 580+ microtiter plates, achieving a 40% reduction in cost and 27% titer increase for cell-free protein synthesis.

  • Ginkgo acquired Zymergen, the original developer of the RAC hardware technology, in 2022.
  • In February 2026, Ginkgo published a technical report with OpenAI demonstrating their autonomous lab capabilities.
  • Ginkgo is systematically decommissioning traditional lab benches in Boston and consolidating all R&D onto a single large autonomous lab in 2026.

The players

Ginkgo Bioworks

A leading synthetic biology company that is building an autonomous lab platform to accelerate scientific discovery and address the reproducibility crisis in biology.

Jason Kelly

The co-founder and CEO of Ginkgo Bioworks, who has been working towards programmable biology infrastructure since the company's founding in 2008.

OpenAI

An artificial intelligence research company that collaborated with Ginkgo on a demonstration of their autonomous lab capabilities.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident

“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”

— Gordon Edgar, grocery employee

What’s next

The judge in the case will decide on Tuesday whether or not to allow Walker Reed Quinn out on bail.

The takeaway

This case highlights growing concerns in the community about repeat offenders released on bail, raising questions about bail reform, public safety on SF streets, and if any special laws to govern autonomous vehicles in residential and commercial areas.